Cargando…
Neutralizing antibody-dependent and -independent immune responses against SARS-CoV-2 in cynomolgus macaques
We examined the pathogenicity of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) in cynomolgus macaques for 28 days to establish an animal model of COVID-19 for the development of vaccines and antiviral drugs. Cynomolgus macaques infected with SARS-CoV-2 showed body temperature rises an...
Autores principales: | Ishigaki, Hirohito, Nakayama, Misako, Kitagawa, Yoshinori, Nguyen, Cong Thanh, Hayashi, Kaori, Shiohara, Masanori, Gotoh, Bin, Itoh, Yasushi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7771262/ https://www.ncbi.nlm.nih.gov/pubmed/33412411 http://dx.doi.org/10.1016/j.virol.2020.12.013 |
Ejemplares similares
-
No Tumorigenicity of Allogeneic Induced Pluripotent Stem Cells in Major Histocompatibility Complex-matched Cynomolgus Macaques
por: Ishigaki, Hirohito, et al.
Publicado: (2021) -
An attenuated vaccinia vaccine encoding the severe acute respiratory syndrome coronavirus-2 spike protein elicits broad and durable immune responses, and protects cynomolgus macaques and human angiotensin-converting enzyme 2 transgenic mice from severe acute respiratory syndrome coronavirus-2 and its variants
por: Ishigaki, Hirohito, et al.
Publicado: (2022) -
Pathogenicity of Pandemic H1N1 Influenza A Virus in Immunocompromised Cynomolgus Macaques
por: Pham, Van Loi, et al.
Publicado: (2013) -
Characterization of tumour-infiltrating lymphocytes in a tumour rejection cynomolgus macaque model
por: Satooka, Hiroki, et al.
Publicado: (2020) -
MHC-identical and transgenic cynomolgus macaques for preclinical studies
por: Ishigaki, Hirohito, et al.
Publicado: (2018)